• Home
  • About
  • Science & Pipeline
  • Leadership
  • News
  • Careers
  • Contact Us
  • LinkedIn
  • Privacy
  • Terms of Use

Phase 1 Placeholder

by dividef | Sep 12, 2020

This is a placeholder. It's hidden from the grid/chart , but necessary to display the filter option until real projects have this category. Keep the category "Hidden"...

Recent Posts

  • Kinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board
  • Kinnate Biopharma Closes $98 Million Series C Financing
  • Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer
  • Precision Oncology News: Kinnate Exiting Stealth Mode With Plans to Move Lead RAF Inhibitor Into Clinical Trials Next Year
  • Kinnate Biopharma Appoints Nima Farzan as Chief Executive Officer

Recent Comments

    Archives

    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • December 2019
    • April 2018

    Categories

    • Article
    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    LinkedIn
    Contact
    Privacy
    Terms of Use
    11975 El Camino Real, Suite 101, San Diego, CA 92130

    © 2020 Kinnate Biopharma.

    Site by GOODLAB